Plenary Lecture

PL Synthetic Sensory Physiology. Dirk Trauner

Intergrated Session

I1-01 Claudin 18.2 targeting antibody-drug conjugate (ADC) prepared by AbClick linker. Sang J. Chung.*
I1-02 Deciphering the Brain Glycocode. Xing Chen.*
I1-03 A Novel Class of Drug Modalities: Generation of Molecular-targeting Helix-loop-helix Peptides via Directed Evolution in Phage-displayed Libraries. Ikuo Fujii.*
I1-04 Engineering Sustainable Resources for CRISPR-based Diagnostics. Chayasith Uttamapinant.*
I1-05 Validation of MOA for Andrographolide in Fission Yeast (S. pombe) Knock-out Library. Chan-Ju Lee, Garam Lee, Jisun Choi, Namshin Kim, Han-Oh Park.*
I2-01 “To B or not to B” in Nucleic Acids Chemistry. Naoki　Sugimoto.*
I2-02 Photo-controllable bioorthogonal reactions and biomolecules. Yan Zhang.*
I2-03 Design of PPI inhibitors by peptide mimics with high membrane permeability. Shinsuke Sando.*
I2-04 Aberrant activation of ClpP protease in bacterial and mammalian cells. .
I2-05 Encoded Display of Chemical Libraries on Nanoparticles as a Versatile Selection Tool for Discovering Protein Ligands. Hyun-Suk Lim.*
I2-06 Bioinformatic analysis reveals both oversampled and underexplored biosynthetic diversity in nonribosomal peptides. John Chu.*
I2-07 Watching single helical membrane proteins fold. Tae-Young Yoon.*
I2-08 Development of 211At-radiopharmaceuticals for Targeted Alpha Therapy in Cancer. Koichi Fukase.*
I3-01 Development of the chemical reactions for regulation of biological function. Fumi Nagatsugi,* Kazumitsu Onizuka, Hidenori Okamura.
I3-02 Phosphorylation Induces α-synuclein to Form Different Strains. Yan-Mei Li.*
I3-03 Deciphering and Engineering of the Biosynthetic Pathways of Microbial Small Molecules for Drug Discovery. Yeo Joon Yoon.*
I3-04 Substrate-controlled Enzymatic Glycosylation for Complex Oligosaccharide Synthesis. Ching-Ching Yu.*
I3-05 The Novel Design Strategy of DNA-Artificial Nucleic Acid Chimera Toward Enhancement of RNase H Mediated RNA Cleavage Activities: Application for COVID-19 Therapeutics. Takehiko WADA.*
I3-06 Molecular design of activatable Raman probes. Mako Kamiya.*
I3-07 Designing Tailored Proteins for Advanced Chemical Biology Applications: Super-Selective Drug Delivery, Chemical Recognition, and More. Yong Ho Kim.*
I4-01 Chemical biology tools based on self-localizing molecules. Shinya Tsukiji.*
I4-02 Bilirubin-based nanomedicine for anticancer and anti-inflammation therapy. Sangyong Jon.*
I4-03 Boronates as Hydrogen Peroxide–Reactive Warheads in the Design of Detection Probes and Prodrugs. Chian-Hui Lai.*
I4-04 Profiling metalloproteomes by chemical and computational proteomics. Chu Wang.*
I4-05 Phase separated protein liquid condensate materials. Yongwon Jung.*
I4-06 Enveloped Virus Replicas self-assembled from beta-Annulus Peptides and Lipids. Kazunori Matsuura.*
I4-07 Twenty Years of Metallomics and Metalloproteomics: From Inorganic Chemical Biology to Drug Development against Emerging Infectious Diseases. Hongzhe Sun,* Hongyan Li, Ying Zhou, Xueying Wei, Jingxin Chen, Shuofeng Yuan, Jasper Fuk-Woo Chan, Ivan Fan-Ngai Hung.

Parallel Session

P1-01 Chemical Tools for Elusive Protein Phosphorylations. Jung-Min Kee.*
P1-02 Spatiotemporally resolved subcellular proteomic profiling with photocatalytic proximity labeling. Peng Zou.*
P1-03 Cytotoxicity and lipophilicity of ruthenium(II) polypyridyl complexes as anti-cancer drugs. Hitoshi Ishida.*
P1-04 Synthetic Anhydromuropeptides as Glycosyl Acceptors of Bacterial Transglycosylase. XIAO-LIN ZHANG, XUE-WEI LIU.*
P1-05 Gene-specific In Vivo mutagenesis for Continuous Directed Evolution. .
P1-06 A molecular altas of subcellular RNA localization and interaction using proximity labeling. Shuo Han.*
P1-07 Design of cell penetrating nanoparticle for drug delivery. An amphipathic α-helical peptide co-assembles into nanoparticle. Soonsil Hyun.*
P1-08 Toward the creation of induced pluripotent small (iPS) molecules inspired by naturally occurring polyene macrolactams. Naoki Kanoh.*
P1-09 Chemical decoding and manipulation of T cell recognition and response. Jie P. Li.*
P1-10 Microscopic DNA sequence visualization. Kyubong Jo.*
P1-11 Point of care testing for biomarkers by intelligent photonic hydrogels. Shao Q. Yao,* Junjie Qin.
P1-12 Molecular design of photocatalytic cross-coupling enzymes. Jaehee Lee, Woon Ju Song.*
P1-13 Multiple functional molecules assembled DNA nanostructure for bioimaging application. Eiji Nakata, Takashi Morii.*
P2-01 Chemical biology of G-quadruplexes based on telomestatin analogs. Masayuki TERA.*
P2-02 Capsid with a Twist: Structure of Pleomorphic Poxvirus Scaffold. Yeontae Jang, Seungmi Kim, Seu-Na Lee, Bum Han Ryu, Jaekyung Hyun.*
P2-03 Dynamic mapping of proteome trafficking within and between living cells by TransitID. Wei Qin.*
P2-04 Drug Discovery Targeting Gut Bacterial B-Glucuronidases to ameliorate the irinotecan-induced toxicity. Chun-Hung Lin.*
P2-05 Chemical Knockdown of Phosphorylated p38 MAPK as a Novel Platform for the Treatment of Alzheimer’s Disease. Nam-Jung Kim.*
P2-06 Optical regulation of protein-protein interactions in living cells using a photochromic dimerizer. Toshiyuki Kowada.*
P2-07 Controllable activation of platinum anticancer prodrugs in vivo. Guangyu Zhu.*
P2-08 Exploring carbohydrate-binding proteins by multivalent affinity labeling probes. Kaori Sakurai.*
P2-09 Tissue-specific drug delivery platforms based on DNA nanostructures. Dae-Ro Ahn.*
P2-10 Deciphering sulfoglycolipids from Mycobacterium tuberculosis to elucidate the structure immunomodulatory activity relationship. Janet Jia-Yin Tan, Kwok-Kong Tony. Mong,* Chun-Hung. Lin.*
P2-11 Micro-sized liquid crystals composed of short double-stranded DNA. Makiko Tanaka.*
P2-12 Mechanistic approach to antibiotic resistance: Mode of action of daptomycin. Zhihong Guo.*
P2-13 Degradable Protein Linkers for pH-Selective Delivery of Protein Drugs. Yan Lee.*

Intergrated Session

I1-01 Claudin 18.2 targeting antibody-drug conjugate (ADC) prepared by AbClick linker. Sang J. Chung.*
I1-02 Deciphering the Brain Glycocode. Xing Chen.*
I1-03 A Novel Class of Drug Modalities: Generation of Molecular-targeting Helix-loop-helix Peptides via Directed Evolution in Phage-displayed Libraries. Ikuo Fujii.*
I1-04 Engineering Sustainable Resources for CRISPR-based Diagnostics. Chayasith Uttamapinant.*
I1-05 Validation of MOA for Andrographolide in Fission Yeast (S. pombe) Knock-out Library. Chan-Ju Lee, Garam Lee, Jisun Choi, Namshin Kim, Han-Oh Park.*
I2-01 “To B or not to B” in Nucleic Acids Chemistry. Naoki　Sugimoto.*
I2-02 Photo-controllable bioorthogonal reactions and biomolecules. Yan Zhang.*
I2-03 Design of PPI inhibitors by peptide mimics with high membrane permeability. Shinsuke Sando.*
I2-04 Aberrant activation of ClpP protease in bacterial and mammalian cells. .
I2-05 Encoded Display of Chemical Libraries on Nanoparticles as a Versatile Selection Tool for Discovering Protein Ligands. Hyun-Suk Lim.*
I2-06 Bioinformatic analysis reveals both oversampled and underexplored biosynthetic diversity in nonribosomal peptides. John Chu.*
I2-07 Watching single helical membrane proteins fold. Tae-Young Yoon.*
I2-08 Development of 211At-radiopharmaceuticals for Targeted Alpha Therapy in Cancer. Koichi Fukase.*
I3-01 Development of the chemical reactions for regulation of biological function. Fumi Nagatsugi,* Kazumitsu Onizuka, Hidenori Okamura.
I3-02 Phosphorylation Induces α-synuclein to Form Different Strains. Yan-Mei Li.*
I3-03 Deciphering and Engineering of the Biosynthetic Pathways of Microbial Small Molecules for Drug Discovery. Yeo Joon Yoon.*
I3-04 Substrate-controlled Enzymatic Glycosylation for Complex Oligosaccharide Synthesis. Ching-Ching Yu.*
I3-05 The Novel Design Strategy of DNA-Artificial Nucleic Acid Chimera Toward Enhancement of RNase H Mediated RNA Cleavage Activities: Application for COVID-19 Therapeutics. Takehiko WADA.*
I3-06 Molecular design of activatable Raman probes. Mako Kamiya.*
I3-07 Designing Tailored Proteins for Advanced Chemical Biology Applications: Super-Selective Drug Delivery, Chemical Recognition, and More. Yong Ho Kim.*
I4-01 Chemical biology tools based on self-localizing molecules. Shinya Tsukiji.*
I4-02 Bilirubin-based nanomedicine for anticancer and anti-inflammation therapy. Sangyong Jon.*
I4-03 Boronates as Hydrogen Peroxide–Reactive Warheads in the Design of Detection Probes and Prodrugs. Chian-Hui Lai.*
I4-04 Profiling metalloproteomes by chemical and computational proteomics. Chu Wang.*
I4-05 Phase separated protein liquid condensate materials. Yongwon Jung.*
I4-06 Enveloped Virus Replicas self-assembled from beta-Annulus Peptides and Lipids. Kazunori Matsuura.*
I4-07 Twenty Years of Metallomics and Metalloproteomics: From Inorganic Chemical Biology to Drug Development against Emerging Infectious Diseases. Hongzhe Sun,* Hongyan Li, Ying Zhou, Xueying Wei, Jingxin Chen, Shuofeng Yuan, Jasper Fuk-Woo Chan, Ivan Fan-Ngai Hung.

Poster Session

PO-01 Excimer Formation Modulation Through Nucleic Acid-Dye Assembly. Dan Bai.*
PO-02 Induced Proximity for Biology and Medicine. Xi,* Simin, Xiaofeng, Chengjian.
PO-03 Mitochondrial specific peptides as novel therapeutics against sarcopenia. Yoonhwa Choi, Dong Heon Lee, Dongmin Kim, Hyeong Woon Choe, Tae Yeon Kim, Hyo Youl Moon,* Jaehoon Yu.*
PO-04 A Cardiolipin-Specific Peptide Ameliorates Obesity and NASH through Mitochondrial Function Restoration. Dongmin Kim.*
PO-05 Novel Self-forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and its Molecular Glue Effect. Abdul Basith Fithroni, Kazuko Kobayashi, Hirotaka Uji, Manabu Ishimoto, Masaru Akehi, Kazunori Watanabe, Eiji Matsuura, Takashi Ohtsuki.*
PO-06 Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors Suppresses Defective Hippo Signaling. Wenchao Lu, Mengyang Fan, Tinghu Zhang, Nathanael Gray.*
PO-07 Selective Detection of Cancer Cells Using a Dual-Targeting Fluorogenic Probe. Yujun KIM, Hyoje JUNG, Injae SHIN.*
PO-08 A fluorogenic probe to differentially monitor both O-GlcNAcase and phosphatase. Jongwon Lee, Jihyeon Boo, Injae Shin.*
PO-10 Dutomycin induces autophagy and apoptosis by targeting the serine protease inhibitor SERPINB6. Jongtae Roh, Taehoon Oh, Sung-Kyun Ko.*
PO-11 Favipiravir ProTides: Enhancing Antiviral Efficiency Against Various Viruses. Thanat Tiyasakulchai, Tanaporn Uengwetwanit, Peera Jaru-ampornpan, Jaraspim Narkpuk, Bunpote Siridechadilok, Suppachoke Onnome, Amporn Suphatrakul, Sewan Theeramunkong, Thitiphong Khamkhenshorngphanuch, Khanit Sa-ngiamsuntorn, Chanya Srisaowakarn, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Nitipol Srimongkolpithak.*
PO-12 Kurarinone induced p53-independent G0/G1 cell cycle arrest by degradation of K-RAS via WDR76 in human colorectal cancer cells. Taehoon OH, Sei-Ryang Oh, Sung-Kyun Ko.*
PO-13 Enantioselective Total Synthesis of Roridin E. Seungbin Park, .
PO-14 Selective citrate-based fluorophore generation on N-terminal cysteine in proteins for bioimaging and histology . Yunjung Choi, Yan Lee.*
PO-15 An engineered influenza virus to deliver antigens for lung cancer vaccination . Demin zhou,* Dezhong Ji,* Yuanjie Zhang.
PO-16 A Fluorescent Probe to Detect Cytosolic and Nuclear O-GlcNAcase. JooHeeChoi, Injae Shin.*
PO-17 Fluorogenic Probes for Detection of Formaldehyde in Cells. Sookil Park, Jinsung Tae, Injae Shin.*
PO-18 Development of a tumor-homing peptide-mediated drug delivery method for magnetic hyperthermia. Shengli Zhou, Ritsuko Imai, Yukiko Miki, Anna Kondo, Hiroshi Nakagawa, Noriyasu Kawai, Kaname Tsutsumiuchi, Kazunori Watanabe, Takashi Ohtsuki.*
PO-19 Identification of proteomic landscape of drug-binding proteins in living cells through proximity-dependent target identification. Cheolhun Park, Chulhwan Kwak, Minjeong Ko, Ho Jeong Kwon,* Eunmi Hong,* Jeong Kon Seo,* Hyun-Woo Rhee.*
PO-20 Super-resolution proximity labeling reveals antiviral protein network and its structural changes against SARS-CoV-2 viral proteins. Yun-Bin Lee, Minkyo Jung, Jeesoo Kim, Afandi Charles, Wanda Christ, Jiwoong Kang, Myeong-Gyun Kang, Chulhwan Kwak, Jonas Klingström, Anna Smed-Sörensen, Jong-Seo Kim,* Ji Young Mun,* Hyun-Woo Rhee.*
PO-21 Endogenous Hydrogen Peroxide Assisted Proximal Cell Labeling. Kwang-eun Kim, InYoung Jeong, Hyun-Woo Rhee.*
PO-22 MitoAtlas, a Mitochondrial Proteome Map Created with Super-Resolution-Proximity-Labeling. Jiwoong Kang, Sang-Hee Shin, Chulhwan Kwak, Sony-Yi Lee, Min-Kyo Jung, Chan Young Kang, Myeong-Gyun Kang, Sangsu Bae, Ji Young Mun, Jong-Seo Kim,* Hyun-Woo Rhee.*
PO-23 Aggregation-induced Emission Luminogen based Photosensitizers for Golgi Apparatus Targeted Cancer Photodynamic Therapy. Yuncong Chen,* Minglun Liu.
PO-24 DESTINI : A Novel Enzyme for Comprehensive Spatial Profiling of Metabolites and Proteins within Cellular Compartments. Chang-Mo Yoo, Hyun-Woo Rhee,* , .
PO-25 Configuration of Amino Acid Residues for Stapling Bim Peptide Affects Both the Secondary Structure and Intracellular Bioactivity. Mizuki Kitamatsu,* Shengli Zhou, Fuka Nishimura, Kazuhaya Wada, Kaho Fujii, Kazunori Watanabe, Takashi Ohtsuki.
PO-26 Development of a Novel Astatine-Labeled Modality for Cancer Therapy. Koki Mayusumi, Kazuya Kabayama, Junichi Takagi, Hiroaki Suga, Kazuhiro Ooe, Atsushi Toyoshima, Koichi Fukase.*
PO-27 Utilization of a simple bidentate catechol analogue as a siderophore mimetic for cytoplasmic delivery of antibiotic, trimethoprim. Do Young Kim, Suyeon Yeom, Jimin Park, Heeyeong Lee, Hak Joong Kim.*
PO-28 Selective Sensing of Nicotinamide Mononucleotide over Citric Acid by the Ratiometric Behaviour of Two Fluorescent Probes. , , .
PO-29 Pyrene-PNA Twin Probe Detects Sequence-specific DNA by the Excimer Fluorescence. Sakura Tsuchitani, Koki Ishii, Yutaka Ouchi, Hajime Shigeto, Shohei Yamamura, Mizuki Kitamatsu.*
PO-30 Secondary Structure of Peptide Is Affected by Chain Length of an Alkyl Cross-linker Used for Stapling. Takahiro Nakamura, Takeshi Kondo, Mizuki Kitamatsu.*
PO-31 Secondary structure of a Bim peptide is stabilized by anchoring its N-terminus. Kazuhaya Wada, Mizuki Kitamatsu.*
PO-32 A Functional Peptide Is Delivered into Cells by a CPP via Peptide-peptide Interactions. Koki Ishii, Yoshiyuki Hakata, Takashi Ohtsuki, Mizuki Kitamatsu.*
PO-33 Raman probe coupling proximity labeling technique for organelle-specific bioimaging. Mohamed Elgawish, Sang-Hee Shim.*
PO-35 Self Assembly of Alkylated Peptide Amphiphiles as a Promising Carrier for siRNA Delivery to Cancer Cells . Taufik Fatwa Nur Hakim, Kazunori Watanabe, Shoumu Fujimoto, Mizuki Kitamatsu, Takashi Ohtsuki.*
PO-36 Development of a Hyperpolarized Molecular Probe for Aminopeptidase N Activity Applicable in vivo. Yutaro Saito, Hiroyuki Yatabe, Iori Tamura, Yohei Kondo, Ryo Ishida, Tomohiro Seki, Keita Hiraga, Akihiro Eguchi, Yoichi Takakusagi, Keisuke Saito, Nobu Oshima, Hiroshi Ishikita, Kazutoshi Yamamoto, Murali C. Krishna, Shinsuke Sando.*
PO-37 Endogenous Fatty Acids Regulation of Bacterial Lipid A Innate Immune Function. Tran Duc Khiem, Shimoyama Atsushi,* Fukase Koichi.*
PO-38 Reaction of a 10B Cluster (BSH) with a Chloroacetyl-modified Peptide Is Facilitated by Basic Amino Acid Residues in the Peptide. Sota Watanabe, Ken Inoue, Hiroyuki Michiue, Mizuki Kitamatsu.*
PO-39 In vivo mitochondrial matrix proteome profiling reveals OPA10/RTN4IP1 as an antioxidant NADPH oxidoreductase oxidoreductase. , , , , , Isaac Park.
PO-40 Elongation of Hydrocarbon Chain Modified to GAVIL Peptide Promotes More Stable Micelle Formation. Shomu Fujimoto, Taufik F.N. Hakim, Takashi Ohtsuki, Mizuki Kitamatsu.*
PO-41 Pyrene-modified Cyclic Peptides Detect Specific Metal Ions by Fluorescence in Water. Yuhi Maekawa, Sora Sakura, Rento Fujihara, Hisashi Sugime, Yuji Furutani, Takashi Ohtsuki, Mizuki Kitamatsu.*
PO-42 Genetically Encodable Click Reactions(GEN-Click) for Spatially Restricted Protein and Metabolite Labeling. Pratyush Kumar Mishra,* Nirmali Sharma, Hyunwoo Kim, Changwook Lee, Hyun-Woo Rhee.*
PO-43 Fluorescence signal amplification using engineered peroxidase (FLEX) for correlative light and electron microscopy imaging approach. Nirmali Sharma, Minkyo Jung, Ji young Mun, Hyun Woo Rhee.*
PO-44 Low-price and easy-to-make polypropylene substrate for inkjet-based oligonucleotide synthesizers. Haeun Kim, Junhyeong Kim, Duhee Bang.*
PO-45 Development of a One-Pot Drug Screening Platform Using 3' RNA Sequencing. Jae-Hee Kim, Jung Won Choi, Jungheun Hyun, Jieun Hyun, Jihyun Lee, Duhee Bang.*
PO-46 Development of an efficient labeled phage display system for the selection of internalizing ligands. Dohee Ahn, Sang J. Chung.*
PO-47 Study of Enzymatic Hydrolysis, Diastereomer Phosphoramidate Prodrug of Acyclovir. Thitiphong Khamkhenshorngphanuch, Sewan Theeramunkong,* Nitipol Srimongkolpithak.*
PO-48 Revealing new phosphoarginine binding proteins using chemoproteomic methods. Seungmin Ahn, Jung-Min Kee.*
PO-49 On-Nanoparticle Display of Encoded Chemical Libraries as a Powerful Tool for Discovering Potent Protein Ligands. Hee Myeong Wang, Kang Ju Lee, Hyun-Suk Lim.*
PO-50 Design and Synthesis of DNA-Encoded Libraries of Peptidic and Peptidomimetic Macrocycles. Jungyeon Kim, Kang Ju Lee, Hyun-Suk Lim.*
PO-51 Computational Design of a light and Ca 2+ switchable Miniprotein. Zinah Hilal Khaleel, , Nam Hyeong Kim,* Yong Ho Kim.*
PO-52 Enhancing Endosomal Escape of siRNA Drugs by Proton Conductance via M2 Channel of Influenza A Virus. Si Yeon Ryu, Nam Hyeong Kim, Seongmin Ga, Yong Ho Kim.*
PO-53 LH peptide, a histidine-based peptide with pH-specific cell penetrating abilities: From tumors and beyond the brain.. Jin-Hyeok Park, So Hee Nam,* Jaehoon Yu,* Yan Lee.*
PO-54 Transcellular peptide-drug conjugate as an effective PDE4 inhibitor for psoriasis-like inflammation. Do Hyun Bae, Hayeon Bae, Yong Ho Kim.*
PO-55 Searching for phosphohistidine readers and acceptors with chemical tools. Solbee Choi, Seungmin Ahn, Jung-Min Kee.*
PO-56 Nanoparticle-enabled on-DNA Grignard reactions for DNA-encoded library synthesis. Muhammad Aliyu Idris,* Dongmin Shin, Hyun-Suk Lim.*
PO-57 Development of Glycogen Synthase Kinase-3β and Carbonic Anhydrase IX Inhibitors by Novel Encoded Library Technology. Jun Hyung Park, Jungyeon Kim, Chang Deok Seo, Hyun-Suk Lim.*
PO-58 Discovery of IL-17 receptor activator by drug repurposing to alleviate social deficits in autism mouse model. Jeeyoung Lee, Sanghee Lee.*
PO-59 Identification of Intracellular Proteases That Degrade Lipidated, Amide-Containing Chimeric Compounds. Kai Tahara, Shinya Tsukiji.*
PO-60 Stimulator of interferon genes (STING) activation triggers immune surveillance and inhibits tumor growth in glioblastoma. Soo Yeon Baek, Sanghee Lee.*
PO-61 Mitochondrial intracristal space (ICS) proteome was revealed by mass detection of isotope-coded post-translational modification by APEX. Myeong-Gyun Kang, Sanghee Shin, Song-Yi Lee, Ohyeon Kwon, Pratyush Kumar Mishra, Minkyo Jung, Ji Young Mun, Jung-Min Kee,* Jong-Seo Kim,* Hyun-Woo Rhee.*
PO-62 De novo protein design for targeted binding of Zolpidem. Jaekyoung Lee, Hyunsub Ji, Yong Ho Kim.*
PO-64 Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy. Yuki Iizuka, Yoshiyuki Manabe, Kazuya Kabayama, Koichi Fukase.*
PO-65 Rice peroxygenase catalyzes lipoxygenase-dependent regiospecific epoxidationof lipid peroxides in the response to abiotic stressors. Anh Duc Tran, Kyoungwon Cho, Oksoo Han.*
PO-66 Gene Editing via CRISPR-Cas9 System for Prolamin Suppression in Rice. Oksoo Han,* Hue Anh Pham.
PO-67 Development of hydrophobic TRAP1 inhibitors. Seonghun Jeong, Bugeon Kim, Nam Gu Yoon, Byoung Heon Kang, Jung-Min Kee.*
PO-68 Engineering Self-Assembled Protein Nanobarrels for Use as Neoantigen-based Cancer Vaccine. Yujin Kim, Seojung Lee, Jungmin Yoon, Ji-Joon Song,* Sangyong Jon.*
PO-69 Mitochondrial thermogenesis promotes protein oligomerization in live cells. Hee Yong Lee, Hwa-Ryeon Kim, Chulhwan Kwak, Myeong-Gyun Kang, Jae-Seok Roe,* Hyun-Woo Rhee.*
PO-70 A New Strategy for the Improved Production of Class I Lanthipeptides in Escherichia coli. Hyunji Lee, Chunyu Wu, Emily K. Desormeaux, Raymond Sarksian, Wilfred A. van der Donk.*
PO-71 Dendronized DNA Chimeras Harness Scavenger Receptors to Degrade Cell Membrane Proteins. Chenghong Zhu, Weishan Wang,* Yan Zhang,* Jinbo Li.*
PO-72 Surface Chemistry for Direct Pancreatic Cancer Detection Using an Optical Fibre Biosensor . Adam Garon, Suresh Venkatachalapathy,* Ricardo Correia, Sergiy Korposh,* Steve Morgan, Seung-Woo Lee, George Gordon, Bapan Pramanik, Alvaro Mata, Guruprasad Aithal, Stuart Astbury.
PO-73 A Self-Assembled Nano-PROTAC Enables Near-Infrared Photo-dynamic Proteolysis for Cancer Therapy. Weishan Wang, Chenghong Zhu,* Yan Zhang,* Jinbo Li.*
PO-74 Cancer cell death using metabolic glycan incorporation techniques. , , Hyemi Jo.
PO-75 Development of novel bioorthogonal conjugation chemistry. On-Yu Kang, Guldana Issabayeva, Seong Yun Choi, Eun Sil Kim, Ji Ho Song, Hwan Jung Lim,* Seong Jun Park.*
PO-76 Development of chemical probes for capturing protein arginine kinases . , .
PO-77 A preliminary study for cancer therapy based on amino acid-combined nanobubbles: an approach to lung cancer cells (A549). Yeawon Park, Seung-Woo Lee.*
PO-78 Investigation of the phase at which caffeine induces death in HepG2 cells. Kazuma Idei.*